Day One Biopharmaceuticals, Inc. (DAWN) Stock News & Chart

(DAWN)

Day One Biopharmaceuticals, Inc.

Stock chart and latest news for Day One Biopharmaceuticals, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Day One Biopharmaceuticals, Inc. News

PRO

Investing.com

Day One Biopharmaceuticals stock reaches 52-week high of $21.48

Apr 13, 2026 Stock Titan

[SC TO-T/A] Day One Biopharmaceuticals, Inc. Amended Third-Party Tender Offer | DAWN SEC Filing - Form SC TO-T/A

Apr 14, 2026 Yahoo Finance

Day One (DAWN) Soars 100% on $2.5-Billion Merger

Mar 7, 2026 Stock Titan

[SC 14D9/A] Day One Biopharmaceuticals, Inc. Amended Tender Offer Recommendation

Apr 14, 2026 simplywall.st

Optimistic Investors Push Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Up 31% But Growth Is Lacking

Jan 21, 2026 Quiver Quantitative

Day One Biopharmaceuticals Reports 172% Year-over-Year Growth in 2025 Net Product Revenue, Projects 2026 Revenue Between $225 Million and $250 Million | DAWN Stock News

Jan 11, 2026 Servier

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio

Mar 6, 2026 Yahoo Finance

Day One (DAWN) Climbs to 3-Year High on $2.5-Billion Merger

Mar 6, 2026 Investing.com Australia

Day One Biopharmaceuticals stock reaches 52-week high of $21.48 By Investing.com

Apr 13, 2026 Stock Titan

Access Industries group tenders Day One (DAWN) 12.9M-share stake at $21.50

Apr 13, 2026 Yahoo Finance

Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?

Jan 13, 2026 Yahoo Finance

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Beats Revenue Estimates

Feb 24, 2026